FID 112903
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FID 112903, covering 2016-11-18 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% [Phase 4]